| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/25/2013 | US20130102682 Fingolimod in the form of a solid solution |
| 04/25/2013 | US20130102681 Compositions and Methods for Inhibiting an Isoform of Human Manganese Superoxide Dismutase |
| 04/25/2013 | US20130102679 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| 04/25/2013 | US20130102678 Enhanced bimatoprost ophthalmic solution |
| 04/25/2013 | US20130102677 Novel solid forms of tacedinaline |
| 04/25/2013 | US20130102675 Solid Pharmaceutical Compositions Containing Pregabalin |
| 04/25/2013 | US20130102674 Methods of treating hypertriglyceridemia |
| 04/25/2013 | US20130102662 Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression |
| 04/25/2013 | US20130102661 Irrigation solutions containing ascorbic acid or its salts and use thereof |
| 04/25/2013 | US20130102660 Medicinal composition intended for the treatment of erectile dysfunction in mammals and use of the composition |
| 04/25/2013 | US20130102659 Salvinorin Compositions and Uses Thereof |
| 04/25/2013 | US20130102658 Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/25/2013 | US20130102645 Methods and compositions for controlling vascularization in ophthalmological and dermatological diseases |
| 04/25/2013 | US20130102644 Prophylactic or Ameliorating Agent for Genetic Diseases |
| 04/25/2013 | US20130102640 Method for the preparation of cis-1,2-diols in the kilogram scale |
| 04/25/2013 | US20130102635 Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal |
| 04/25/2013 | US20130102633 Transglutaminase inhibitors and methods of use thereof |
| 04/25/2013 | US20130102630 Derivatives of the Aminated Hydroxyquinoline Class For Treating Cancers |
| 04/25/2013 | US20130102625 Artemisinin with Berberine Compositions and Methods of Making |
| 04/25/2013 | US20130102619 2-pyridyloxy-4-nitrile orexin receptor antagonists |
| 04/25/2013 | US20130102616 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 04/25/2013 | US20130102615 Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| 04/25/2013 | US20130102614 Chirally pure isomers of itraconazole for use as angiogenesis inhibitors |
| 04/25/2013 | US20130102612 Topical dermal brimonidine compositions |
| 04/25/2013 | US20130102608 Bipyridyl derivatives |
| 04/25/2013 | US20130102606 Compositions and Methods for Stimulating Collagen Synthesis in the Skin |
| 04/25/2013 | US20130102603 2,4-diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 04/25/2013 | US20130102602 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions |
| 04/25/2013 | US20130102601 Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | US20130102600 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | US20130102596 Method and device for administering xinafoate salt of n4-(2,2-difluoro-4h-benzo [1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3- (methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine |
| 04/25/2013 | US20130102594 Pharmaceutical Formulation of Valsartan |
| 04/25/2013 | US20130102591 Compositions and methods for prevention and treatment of pulmonary hypertension |
| 04/25/2013 | US20130102590 Pyridopyrimidinone inhibitors of kinases |
| 04/25/2013 | US20130102589 Novel Compound for the Treatment of Hepatitis C |
| 04/25/2013 | US20130102588 Tolvaptan solid dispersion and its preparation method |
| 04/25/2013 | US20130102584 Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors |
| 04/25/2013 | US20130102581 Composition and method for treatment of diabetes |
| 04/25/2013 | US20130102576 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | US20130102575 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof |
| 04/25/2013 | US20130102574 2-methylene-vitamin d analogs and their uses |
| 04/25/2013 | US20130102573 2-methylene-vitamin d analogs and their uses |
| 04/25/2013 | US20130102572 Methods of treating skin conditions exhibiting telangiectasia |
| 04/25/2013 | US20130102570 Prophylactic agent or therapeutic agent for diabetes or obesity |
| 04/25/2013 | US20130102569 Methods and Compositions for Preventing or Treating Age-Related Diseases |
| 04/25/2013 | US20130102567 3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses |
| 04/25/2013 | US20130102566 Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings |
| 04/25/2013 | US20130102565 Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopedic surgery |
| 04/25/2013 | US20130102563 Dermal filler with lidocaine |
| 04/25/2013 | US20130102562 Inhibition of cathepsin k activity and the treatment and prevention of disease |
| 04/25/2013 | US20130102561 Stabalized Glycosaminoglycan Preparations and Related Methods |
| 04/25/2013 | US20130102560 Nutritional composition comprising immunoglobulins and oligosaccharides |
| 04/25/2013 | US20130102559 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 04/25/2013 | US20130102558 Methods for Treating HCV |
| 04/25/2013 | US20130102557 Methods for Treating HCV |
| 04/25/2013 | US20130102556 Use of N1,N4-bis[3-(Ethylamino)Propyl]-2-Butene-1,4-Diamine Compounds in Combination with Epigenetic-Acting Pharmaceuticals for Enhanced Cancer Therapy |
| 04/25/2013 | US20130102555 Method of treating diabetes |
| 04/25/2013 | US20130102554 Composition for treatment of obesity using wheat bran extract or active ingredient isolated therefrom |
| 04/25/2013 | US20130102553 Therapeutic Strategies For Prevention And Treatment Of Alzheimer's Disease |
| 04/25/2013 | US20130102551 Antibiotic compositions |
| 04/25/2013 | US20130102549 VEGF Production Promoter |
| 04/25/2013 | US20130102548 Pharmaceutical delivery system |
| 04/25/2013 | US20130102546 Methods of treating vascular inflammatory disorders |
| 04/25/2013 | US20130102545 Temperature dependent activation of catalytic nucleic acids for controlled active substance release |
| 04/25/2013 | US20130102544 Disease-Associated Proteins |
| 04/25/2013 | US20130102543 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 04/25/2013 | US20130102538 Method of treating alzheimer's disease using pharmacological chaperones to increase presenilin function and gamma-secretase activity |
| 04/25/2013 | US20130102526 Methods for Treating HCV |
| 04/25/2013 | US20130102525 Methods for Treating HCV |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |
| 04/25/2013 | US20130102014 Fluorinated resorufin compounds and their application |
| 04/25/2013 | US20130101690 Supplements and methods of supplementation |
| 04/25/2013 | US20130101686 Topical Composition and Use Thereof for the Prophylaxis and the Treatment of Defects Connected to Inflammatory Dermopathies |
| 04/25/2013 | US20130101681 Use of chromium histidinate for treatment of cardiometabolic disorders |
| 04/25/2013 | US20130101680 Radiotherapy enhancer |
| 04/25/2013 | US20130101679 Cholestanol derivative for combined use |
| 04/25/2013 | US20130101678 Compositions and Methods for Treating Vaginal Infections and Pathogenic Vaginal Biofilms |
| 04/25/2013 | US20130101668 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals: oxidation of coordinated benzimidazole to omeprazole |
| 04/25/2013 | US20130101667 Cyclohexylamines |
| 04/25/2013 | US20130101666 Liposome including elastin-like polypeptide conjugated to moiety containing hydrophobic group, chemosensitizer and anticancer agent and use thereof |
| 04/25/2013 | US20130101663 Soluble tumor necrosis factor receptor (sTNF-R) used as a targeting agent to treat arthritis and other diseases |
| 04/25/2013 | US20130101660 Transdermal delivery patch |
| 04/25/2013 | US20130101657 Angiogenesis inhibitors |
| 04/25/2013 | US20130101656 In situ gelling drug delivery system |
| 04/25/2013 | US20130101653 Methods and materials for reducing the risk of infections |
| 04/25/2013 | US20130101650 Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol |
| 04/25/2013 | US20130101644 Tocotrienol compositions |
| 04/25/2013 | US20130101634 Compositions and methods for reducing microbial overgrowth in the small intestines |
| 04/25/2013 | US20130101632 Nanoparticulate formulations of mithramycin or mithramycin analogues for treating cancer |
| 04/25/2013 | US20130101630 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
| 04/25/2013 | US20130101629 Homogenous suspension of immunopotentiating compounds and uses thereof |
| 04/25/2013 | US20130101625 Modified cea nucleic acid and expression vectors |
| 04/25/2013 | US20130101622 Imidazoquinoxaline compounds as immunomodulators |
| 04/25/2013 | US20130101616 Compositions of botanical extracts for cancer therapy |
| 04/25/2013 | US20130101615 Methods for preventing or treating a disease or condition associated with mycobacterium avium subspecies paratuberculosis |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101582 Tiki1 and Tiki2, Wnt Inhibitors |
| 04/25/2013 | US20130101580 Compositions and methods for prolonging lifespan |
| 04/25/2013 | US20130101572 Compositions and methods for treatment of vitiligo |